Charge Heterogeneity Analysis Service
Charge heterogeneity refers to the differences in the charge state or isoelectric point (pI) of protein molecules due to variations in amino acid sequences, chemical modifications, or post-translational modifications (PTMs). Common sources of charge heterogeneity include deamidation, oxidation, glycosylation modifications, enzymatic cleavage, and carboxyl/amine modifications. These variations can significantly impact protein stability, half-life, immunogenicity, and bioactivity, which in turn affects the therapeutic efficacy and safety of biopharmaceutical products.
For therapeutic antibodies, recombinant proteins, vaccines, and other biologics, charge heterogeneity analysis has become an indispensable part of quality control and regulatory submission processes. International pharmacopoeias (such as USP, Ph. Eur.) and ICH Q6B guidelines clearly state that systematic characterization and control of protein charge variants are essential to ensure product consistency and controllability.
Leveraging multi-platform analysis systems and extensive protein characterization experience, MtoZ Biolabs provides comprehensive and high-resolution Charge Heterogeneity Analysis Service to uncover the existence and sources of charge variants, supporting the entire process of new drug development, production release, and quality traceability.
Services at MtoZ Biolabs
To meet research needs, MtoZ Biolabs’ charge heterogeneity analysis service is divided into two main dimensions: detection platform of charge heterogeneity and charge heterogeneity characterization.
|
Charge Heterogeneity Analysis Platforms
|
Isoelectric Focusing Electrophoresis |
| Ion Chromatography | |
| cIEF | |
| Two-Dimensional Gel Electrophoresis | |
| LC-MS | |
| Capillary Electrophoresis | |
|
Charge Heterogeneity Characterization |
Charge Variant Analysis |
| Monosaccharide Composition Analysis | |
| Sialic Acid Content Analysis | |
| Other Post-Translational Modification Analysis | |
| Comprehensive Glycosylation Analysis | |
| Protein Isoelectric Point Determination |
Analysis Workflow
Service Advantages
1. Multi-Platform Integrated Detection
MtoZ Biolabs has built a charge heterogeneity analysis platform that integrates IEX, cIEF, IEF, and MS techniques, enabling the detection of charge variants and minor modifications. This approach helps clients fully understand the mechanisms of variant formation.
2. Experienced Analytical Team
Our team has years of experience in characterizing complex biologics, such as antibodies, fusion proteins, and enzyme preparations. We are familiar with pharmacopoeial standards and regulatory submission requirements, offering practical and actionable testing recommendations and data support.
3. Mass Spectrometry for In-Depth Analysis
Combining high-resolution LC-MS/MS, we provide peptide-level and site-specific confirmation of protein modifications, offering highly sensitive detection of deamidation and oxidation.
4. Transparent Pricing
Our pricing is clear and straightforward, with no hidden fees or additional costs, ensuring that you know exactly what you are paying for.
5. Comprehensive Reporting and Regulatory Support
We provide detailed, compliant reports that can support regulatory filings, including IND and BLA submissions.
Applications
1. Early-stage Biopharmaceutical Development and CMC Studies
2. Consistency Evaluation Before and After Process Changes
3. Batch Release Testing and Stability Studies
4. Structural Characterization for IND/BLA Submissions
5. Micro-Difference Detection in Glycoengineered Antibodies and Fusion Proteins
FAQs
Q1: Are the results from IEX and cIEF consistent?
A1: These two techniques are based on different principles— IEX focuses on surface charge interactions, while cIEF separates proteins based on their isoelectric point. Their results are complementary, and we recommend using them together to achieve a more complete variant profile.
Q2: Can we only conduct qualitative analysis for variants?
A2: Yes. We can provide either qualitative or quantitative services according to your needs. We can also perform additional analysis for modification sources if required, offering a progressive testing strategy.
Sample Submission Suggestions
1. Sample Types: Recombinant proteins, antibodies, fusion proteins, vaccines, and other aqueous formulations.
2. Recommended Concentration: ≥1 mg/mL (may be adjusted for IEX/cIEF analysis).
3. Recommended Volume: ≥100 µL.
4. Buffer System: Avoid high-salt, sugary, or colored solutions. Please consult us for detailed sample submission guidelines.
Deliverables
1. Complete Charge Variant Detection Profile (IEX, cIEF, or IEF results).
2. Modification Source Analysis Report (including mass spectrometry data, modification sites, and quantitative results).
3. Isoelectric Point and Variant Distribution Maps.
4. Monosaccharide and Glycan Structure Analysis Report (if applicable).
MtoZ Biolabs is dedicated to providing high-quality charge heterogeneity analysis service to biopharmaceutical R&D and manufacturing companies worldwide. We understand the importance of charge heterogeneity analysis for product stability and regulatory compliance, and with our multi-platform approach and expert team, we help you efficiently identify and address protein charge variants.
If you have any testing needs, feel free to contact us for customized solutions and technical support.
Related Services
How to order?
